A Multi-center Long Term Efficacy Trial of the GFX For Reduction of Glabellar Furrowing
Public ClinicalTrials.gov record NCT00611273. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Long term efficacy study of GFX for patients undergoing reduction of glabellar furrowing
Study identification
- NCT ID
- NCT00611273
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 260 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2007 (Type not available)
- Primary completion
- Apr 2008 (Actual)
- Completion
- Apr 2008 (Actual)
- Last update posted
- Jun 24, 2014
2007 – 2008
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Paul S. Nassif, MD, FACS | Beverly Hills | California | 90212 | — |
| James Newman | San Mateo | California | 94401 | — |
| Michael E. Jansin, MD | Tampa | Florida | 33613 | — |
| Foad Nahai, M.D., F.A.C.S. | Atlanta | Georgia | 30327 | — |
| Steven P. Block, MD | Highland Park | Illinois | 60035 | — |
| Keith LaFerriere, MD | Springfield | Missouri | 65807 | — |
| J. Smythe Rich, III, M.D | Columbia | South Carolina | 29203 | — |
| Russell W. Kridel, MD | Houston | Texas | 77030 | — |
| Roger C. Mixter, MD | Milwaukee | Wisconsin | 53217 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00611273, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2014 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00611273 live on ClinicalTrials.gov.